Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/01/21
End: 03/31/23
Due: 03/31/24
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 04/30/15
End: -
Due: -
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation. | NCT04756622 | moshe yeshurun | user2@example.com | None | 2021-04-01 | 2023-03-31 | 2024-03-31 | - | - | 2025-07-14 |
| Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation | NCT01940562 | moshe yeshurun | user2@example.com | None | 2013-10-31 | 2016-06-30 | 2017-06-30 | - | - | 2025-07-14 |
| Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease | NCT02392780 | moshe yeshurun | user2@example.com | None | 2015-04-30 | - | - | - | - | 2025-07-14 |